INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$120K

$120,128

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
CTNM M Contineum Therapeutics, Inc. Stengone Carmine N. • CEO Other 2026-02-25 $3,402 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO Other	2026-02-25	$3,402	M	Form 4
CTNM S Contineum Therapeutics, Inc. Stengone Carmine N. • CEO 10b5-1 SellΔOwn -15.3% 2026-02-25 $43,242 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO 10b5-1 SellΔOwn -15.3%	2026-02-25	$43,242	S	Form 4
CTNM M Contineum Therapeutics, Inc. Stengone Carmine N. • CEO Other 2026-02-24 $5,544 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO Other	2026-02-24	$5,544	M	Form 4
CTNM S Contineum Therapeutics, Inc. Stengone Carmine N. • CEO 10b5-1 SellΔOwn -22.7% 2026-02-24 $70,486 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO 10b5-1 SellΔOwn -22.7%	2026-02-24	$70,486	S	Form 4
CTNM M Contineum Therapeutics, Inc. Stengone Carmine N. • CEO Other 2026-02-11 $504 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO Other	2026-02-11	$504	M	Form 4
CTNM S Contineum Therapeutics, Inc. Stengone Carmine N. • CEO 10b5-1 Sell 2026-02-11 $6,400 View Form 4 →
CTNM	Contineum Therapeutics, Inc.	Stengone Carmine N. CEO 10b5-1 Sell	2026-02-11	$6,400	S	Form 4